← Back
$AVBP All transactions

ArriVent BioPharma, Inc.

A

$ Value

$0

Shares

130,000

Price

$0

Filed

Feb 4

Insider

Name

Kastenmayer James Paul

Title

General Counsel

CIK

0001798800

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

130,000

Footnotes

The shares underlying this option vest as to 25% on February 2, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Filing Info

Accession No.

0001104659-26-010471

Form Type

4

Issuer CIK

0001868279

Kastenmayer James Paul's History

Date Ticker Type Value
2026-02-02 AVBP A $0

Other Insiders at AVBP (90d)

Insider Bought Sold Last
Yao Zhengbin
President and CEO
2026-02-02
HILLHOUSE INVESTMENT MANAGEMENT, LTD. $13.0M 2025-12-10
Kung Winston
Chief Financial Officer
2026-02-02
LaChapelle Robin
Chief Operating Officer
2026-02-02
Lutzker Stuart
President of R&D
2026-02-02